Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
Completed
Conditions studied: Colitis, Ischemic
In brief
The purpose of this study is to study the demographic,laboratory,endoscopic, and outcomes of ischemic colitis patient presented with severe lower gastrointestinal bleeding compared to other diagnoses.
Key facts
- Study ID
- NCT01078324
- Run by
- University of California, Los Angeles
- People needed
- 550
- Starts
- 1997-12-01
- Expected to finish
- 2009-12-01
- Last updated by the study team
- 2016-08-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- bright red blood clots or burgundy colored stool documented by a health care worker
- clinical or laboratory evidence of significant blood loss, manifested by any one of the following: (a) more than three bloody bowel movements in eight hours (b) a decrease of two grams of hemoglobin (Hgb) from baseline, or (c) transfusion of more than three units of red blood cell (URBC).
You may not qualify if…
- age less than 18 year
- history of inflammatory bowel disease
- hypotension or shock refractory to resuscitation
- severe coagulopathy refractory to resuscitation (platelet count < 30,000; prothrombin time [PT]- more than 2 times normal; partial thromboplastin time [PTT]- more than 2 times normal)
- acquired immune deficiency syndrome or neutropenia
- the inability to provide informed consent
- documentation of anal disorders as a cause of bleeding such as internal hemorrhoids, anal fissures, polyps or cancer of the anal canal, and fistulae
Where it is running
- The Veterans Affairs Greater Los Angeles Medical Center — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.